Plasma homocysteine and calcific aortic valve disease

Authors:

Abstract
We retrospectively analysed 76 patients with a mean (SD) age of 66 (13) years, (65% male) who underwent cardiac surgery at the Cleveland Clinic Foundation with intraoperative transoesophageal echocardiography. The patients were originally recruited for a prospective study assessing the relation between plasma homocysteine and aortic atheroma. Exclusion criteria were chronic renal failure, rheumatic heart disease, and known malignancy. All subjects gave informed consent and our institutional review board approved the study. All patients had fasting plasma homocysteine concentrations obtained on the day of their preoperative evaluation or on the morning of surgery. Venous blood was placed into a heparinised tube on ice, centrifuged within 10 minutes of blood being drawn, and analysed using a microparticle enzyme immunoassay. Normal plasma homocysteine ranges in our laboratory are 6.4–13.7 μmol/l for men and 3.4–12.9 μmol/l for women.